[go: up one dir, main page]

EP0162194A1 - Inoculating alloy for the production of nodular cast iron - Google Patents

Inoculating alloy for the production of nodular cast iron Download PDF

Info

Publication number
EP0162194A1
EP0162194A1 EP85101529A EP85101529A EP0162194A1 EP 0162194 A1 EP0162194 A1 EP 0162194A1 EP 85101529 A EP85101529 A EP 85101529A EP 85101529 A EP85101529 A EP 85101529A EP 0162194 A1 EP0162194 A1 EP 0162194A1
Authority
EP
European Patent Office
Prior art keywords
alloy
inoculation
cast iron
base alloy
inoculating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85101529A
Other languages
German (de)
French (fr)
Inventor
Hans Dr.-Ing. Heyer
Karl Dr.-Ing. Ableidinger
Dieter Dr.-Ing. Rabus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ingenieurbuero Dr-Ingkarl Ableidinger Dr-Inghans Heyer
Original Assignee
Ingenieurbuero Dr-Ingkarl Ableidinger Dr-Inghans Heyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingenieurbuero Dr-Ingkarl Ableidinger Dr-Inghans Heyer filed Critical Ingenieurbuero Dr-Ingkarl Ableidinger Dr-Inghans Heyer
Publication of EP0162194A1 publication Critical patent/EP0162194A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C21METALLURGY OF IRON
    • C21CPROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C1/00Refining of pig-iron; Cast iron
    • C21C1/10Making spheroidal graphite cast-iron
    • C21C1/105Nodularising additive agents

Definitions

  • the invention relates to a seed alloy for the production of spherulitic cast iron, - from an Fe-Si base alloy with additions of at least one metal from the rare earth group, from at least one element from the alkaline earth group, from Bi and A1.
  • Spherolithic cast irons are usually made from a near eutectic alloy.
  • the aim is to form the largest possible number of spherulites per unit area, because the properties of cast iron, in particular its ductility, are improved with an increasing number of spherulites.
  • the inoculant is e.g. melt in a ladle before pouring into e.g. granular shape.
  • a known inoculation alloy of the type described at the beginning (DE-OS 32 29 153) is added in amounts of up to 1.3 percent by weight to the melt.
  • the more seed alloy is added the greater the number of spherulites formed in the cast iron.
  • white radiation which is based on the formation of Fe 3 G
  • a special form vaccination is therefore also used, ie. one places inoculation stones from the inoculation alloy in certain places of the form.
  • the object of the invention is to provide a vaccine alloy of the type described at the outset, which results in a self-feeding Behavior of the solidifying melt and makes the use of a special mold vaccination unnecessary.
  • the inoculation alloy contains C beyond the solution equilibrium of the Fe-Si base alloy and is accordingly free of metal oxides.
  • the nucleation in the melt and thus the number of spherulites formed can be controlled much better when using an inoculation alloy according to the invention.
  • This also provides the prerequisites for achieving a self-feeding behavior of the cooling melt by adding a certain amount of the inoculant.
  • the specific effect of the carbon of the seed alloy is not known in detail. However, it is believed that the carbon in the inoculant on the one hand and in the melt on the other hand helps to suppress oxygen activity.
  • the affinity of the relatively high C content in the production of the inoculation alloy leads to deoxidation, which limits the oxygen activity of the inoculation alloy before the alloying of the microalloys, so that these are retained as metals and with their activity a reproducible and targeted vaccination treatment during the Solidification can be brought up in response to the oxygen escaping from the solidification fronts.
  • the activity of the combination of microalloys forms a reproducible number of germs that contribute to a high number of spherulites the solidification of a cast iron melt in sand and mold shapes and lead to a self-feeding characteristic of the liquid, near-eutectic cast iron during the solidification.
  • the cast iron melt can be completely inoculated before the pouring, without the need for subsequent vaccination during the pouring or pouring in the form of a mold vaccination.
  • a method for producing the inoculation alloy in which the base alloy is first melted and the additives are added shortly before or during the cooling phase, which is characterized in that the base alloy C is added in an amount which suppresses the oxygen activity of the base alloy.
  • the base alloy C is added in an amount which suppresses the oxygen activity of the base alloy.
  • the inoculating alloy can contain up to 5 percent by weight, preferably 3 percent by weight, of carbon.
  • the following directional analysis is proposed for an inoculant for pearlitic GuB quality.
  • the rest Fe is first a base alloy of Si and Fe melted at a temperature of 1400 degrees Celsius. C is added to the base alloy in an amount that on the one hand lowers the oxygen activity of the base alloy and on the other hand leads to a C content of approx. 3.0 percent by weight in the finished inoculation alloy. Shortly before the cooling phase, the additives Ca, Al, Ce, Bi are added to the base melt. The inoculation alloy is brought into granular form.
  • This inoculant is used to produce a ductile GuBei - Spherolithic casting quality from a eutectic alloy in an amount of 0.3 percent by weight of the Mg-pretreated melt contained in a pouring pan was added shortly before the casting.
  • the melt shows a self-feeding behavior when it cools down.
  • Test results are summarized under a), in which the percentage content of various additives was varied. Under b) the test results with the respective opti paint vaccine alloys specified. The test results with the vaccine alloy D from DE-OS 32 29 153 are reproduced under c). The better results are attributed, among other things, to the relatively higher Ca content.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Refinement Of Pig-Iron, Manufacture Of Cast Iron, And Steel Manufacture Other Than In Revolving Furnaces (AREA)

Abstract

The alloy for treating nodular cast iron consists of an Fe-Si base alloy with additions of at least one metal from the rare earths group, at least one metal from the alkaline earths group, of Bi and Al. To obtain self-feeding behaviour of the melt treated with the inoculation alloy, while dispensing with specific inoculation in the mould, the inoculation alloy should contain carbon beyond the solution equilibrium of the Fe-Si-base alloy and be essentially free of metal oxides.

Description

Die Erfindung betrifft eine Impflegierung zur Herstellung von sphärolithischem Gußeisen, - aus einer Fe-Si-Basislegierung mit Zusätzen von mindestens einem Metall der Gruppe seltener Erden, von mindestens einem Element der Gruppe Erd-alkali, von Bi und A1.The invention relates to a seed alloy for the production of spherulitic cast iron, - from an Fe-Si base alloy with additions of at least one metal from the rare earth group, from at least one element from the alkaline earth group, from Bi and A1.

Sphärolithische Gußeisen werden in der Regel aus einer naheutektischen Legierung hergestellt. Angestrebt wird die Bildung einer möglichst großen Zahl von Sphärolithen pro Flächeneinheit, weil mit steigender Zahl von Sphärolithen die Eigenschaften des Gußeisens, insbesondere seine Duktilität, verbessert werden. Die Impflegierung wird der z.B. in einem Gießpfännchen befindlichen Schmelze vor dem Abgießen in z.B. körniger Form.zugegeben.Spherolithic cast irons are usually made from a near eutectic alloy. The aim is to form the largest possible number of spherulites per unit area, because the properties of cast iron, in particular its ductility, are improved with an increasing number of spherulites. The inoculant is e.g. melt in a ladle before pouring into e.g. granular shape.

Eine bekannte Impflegierung der eingangs beschriebenen Gattung (DE-OS 32 29 153) wird in Mengen von bis zu 1,3 Gewichtsprozent der Schmelze zugegeben. Je mehr Impflegierung zugegeben wird, desto größer ist die Zahl der im Gußeisen gebildeten Sphärolithen. In der Praxis hat sich allerdings gezeigt, daß selbst unter im wesentlichen gleichen Verhältnissen die Zahl der Sphärolithen in einem relativ großen Bereich schwanken kann. Um sicherzugehen, daß insbesondere in dünnwandigen Bereichen des Gußstückes keine sogenannte Weißeinstrahlung entsteht, die auf der Bildung von Fe3G beruht, setzt man deshalb zusätzlich eine spezielle Formimpfung ein, d.h.. man legt an bestimmte Stellen der Form Impfsteine aus der Impflegierung ein. Im Zusammenhang mit der schwankenden Zahl der gebildeten Sphärolithe steht auch ein anderes Problem, nämlich die unterschiedliche Schrumpfung der erstarrenden Schmelze, weil die metallische Schrumpfung jeweils in Abhängigkeit vom Volumen der gebildeten Spherolithe durch die Expansion des Graphits ausgeglichen wird.A known inoculation alloy of the type described at the beginning (DE-OS 32 29 153) is added in amounts of up to 1.3 percent by weight to the melt. The more seed alloy is added, the greater the number of spherulites formed in the cast iron. In practice, however, it has been shown that the number of spherulites can fluctuate within a relatively large range even under essentially the same conditions. In order to ensure that, especially in thin-walled areas of the casting, there is no so-called white radiation, which is based on the formation of Fe 3 G, a special form vaccination is therefore also used, ie. one places inoculation stones from the inoculation alloy in certain places of the form. There is also another problem in connection with the fluctuating number of spherulites formed, namely the different shrinkage of the solidifying melt, because the metallic shrinkage is compensated for by the expansion of the graphite depending on the volume of the spherulites formed.

Aufgabe der Erfindung ist es, eine Impflegierung der eingangs beschriebenen Gattung anzugeben, die zu einem selbstspeisenden Verhalten der erstarrenden Schmelze führt und den Einsatz einer speziellen Formimpfung überflüssig macht.The object of the invention is to provide a vaccine alloy of the type described at the outset, which results in a self-feeding Behavior of the solidifying melt and makes the use of a special mold vaccination unnecessary.

Diese Aufgabe wird dadurch gelöst, daß die Impflegierung über das Lösungsgleichgewicht der Fe-Si-Basislegierung hinaus C enthält und entsprechend metalloxidfrei ist. Überraschenderweise hat sich gezeigt, daß bei Einsatz einer erfindungsgemäßen Impflegierung die Keimbildung in der Schmelze und damit die Zahl der entstehenden Sphärolithe wesentlich besser beherrscht werden können. Damit sind auch die Voraussetzungen gegeben, durch Zusatz einer bestimmten Menge der Impflegierung ein selbstspeisendes Verhalten der abkühlenden Schmelze zu erreichen. Außerdem kann auf spezielle Formimpfung verzichtet werden. Die spezifische Wirkung des Kohlenstoffs der Impflegierung ist im einzelnen nicht bekannt. Man geht jedoch davon aus, daß der Kohlenstoff einerseits in der Impflegierung und andererseits in der Schmelze zur Unterdrückung der Sauerstoffaktivität beiträgt..This object is achieved in that the inoculation alloy contains C beyond the solution equilibrium of the Fe-Si base alloy and is accordingly free of metal oxides. Surprisingly, it has been found that the nucleation in the melt and thus the number of spherulites formed can be controlled much better when using an inoculation alloy according to the invention. This also provides the prerequisites for achieving a self-feeding behavior of the cooling melt by adding a certain amount of the inoculant. In addition, there is no need for special vaccinations. The specific effect of the carbon of the seed alloy is not known in detail. However, it is believed that the carbon in the inoculant on the one hand and in the melt on the other hand helps to suppress oxygen activity.

Eine Kombination der Elemente Ca, CeM und Bi als Mikrolegierungen, die durch ihre Aktivität infolge ihrer hohen Affinität zum Sauerstoff und anderen Elementen eine besonders hohe Keimbildungsbereitschaft hat, führt beim Vorliegen einer Rest-Sauerstoffaktivität in einer Mg-behandelten Gußeisenschmelze zur Vermeidung der Unterkühlung während der Erstarrung und damit zur Vermeidung der Erstarrung im metastabilen System der Eisen-Legierung auch bei hohen Abkühlungsgeschwindigkeiten bzw. in dünnen Querschnitten (Vermeidung der Karbidbildung, Weißeinstrahlung etc.). Des weiteren führt die Affinität des relativ hohen C-Gehaltes bei der Erzeugung der Impflegierung zu einer Desoxydation, die die Sauerstoffaktivität der Impflegierung vor dem Zulegieren der Mikrolegierungen begrenzt, so daß diese als Metalle erhalten bleiben und mit ihrer Aktivität eine reproduzierbare und gezielte Impfbehandlung während der Erstarrung in Reaktion mit dem an den Erstarrungsfronten ausseigernden Sauerstoff erzieht werden kann. Die Aktivität der Kombination der Mikrolegierungen bildet eine reproduzierbare Anzahl von Keimen, die zu einer-hohen Anzahl an Sphärolithen bei der Erstarrung einer Gußeisenschmelze in Sand-und Kokillenformen und zu einer selbstspeisenden Charakteristik des flüssigen, naheutektischen Gußeisens während der Erstarrung führen. Die Gußeisenschmelze kann vor dem Vergießen vollständig geimpft werden, ohne daß eine Nachimpfung während des Umgießens oder Vergießens in Form einer Formimpfung erfolgen muß.A combination of the elements Ca, CeM and Bi as microalloys, which due to their activity due to their high affinity for oxygen and other elements has a particularly high willingness to nucleate, leads to the prevention of hypothermia during the presence of residual oxygen activity in a Mg-treated cast iron melt Solidification and thus to avoid solidification in the metastable system of the iron alloy even at high cooling speeds or in thin cross sections (avoiding carbide formation, white radiation etc.). Furthermore, the affinity of the relatively high C content in the production of the inoculation alloy leads to deoxidation, which limits the oxygen activity of the inoculation alloy before the alloying of the microalloys, so that these are retained as metals and with their activity a reproducible and targeted vaccination treatment during the Solidification can be brought up in response to the oxygen escaping from the solidification fronts. The activity of the combination of microalloys forms a reproducible number of germs that contribute to a high number of spherulites the solidification of a cast iron melt in sand and mold shapes and lead to a self-feeding characteristic of the liquid, near-eutectic cast iron during the solidification. The cast iron melt can be completely inoculated before the pouring, without the need for subsequent vaccination during the pouring or pouring in the form of a mold vaccination.

Durch die selbstspeisende Charakteristik des Gußeisens ist es nurmehr notwendig, die liquide Schrumpfung im Temperaturbereich oberhalb Liquidustemperatur durch eine Nachspeisung auszugleichen. Im Temperaturbereich zwischen Liquidus- und Solidustemperatur ist durch die gezielte Keimbildungsbereitschaft der Schmelze, die optimale Graphitausscheidung und die damit verbundene hohe Anzahl von Sphärolithen und deren Expansion während der Erstarrung eine Nachspeisung nicht erforderlich. Das bedeutet ein wesentlich höheres Ausbringen als Verhältnis vergossenes Flüssigeisen zu gutem Guß sowie geringere Form- und Putzarbeiten. Nicht zuletzt führt die dichte Erstarrungsstruktur zu besseren mechanisch-technologischen Eigenschaften und damit zu einer höheren Konstruktionssicherheit.Due to the self-feeding characteristics of cast iron, it is only necessary to compensate for the liquid shrinkage in the temperature range above the liquidus temperature by making up water. In the temperature range between liquidus and solidus temperature, the targeted readiness for nucleation of the melt, the optimal graphite precipitation and the associated high number of spherulites and their expansion during solidification mean that a refill is not necessary. This means a much higher output than the ratio of poured liquid iron to good casting and less molding and cleaning work. Last but not least, the dense solidification structure leads to better mechanical-technological properties and thus to higher construction reliability.

In diesem Zusammenhang wird erfindungsgemäß ein Verfahren zum Herstellen der Impflegierung vorgeschlagen, wobei zunächst die Basislegierung erschmolzen und kurz vor oder während der Abkühlungsphase die Zusätze beigegeben werden, welches dadurch gekennzeichnet ist, daß der Basislegierung C in einer die Sauerstoffaktivität der Basislegierung unterdrückenden Menge zugegeben wird. Wenn Kohlenstoff bereits der Basislegierung zugegeben wird, dann stellt sich in der Schmelzphase der Basislegierung eine Gleichgewichtsreaktion Si-C-0 ein, die hauptsäch- lich zur Bildung/CO führt, welches als Gasphase entweicht. Die später zugegebenen Zusätze, insbesondere diejenigen, die eine große Sauerstoffaktivität aufweisen, können dann in der abkühlenden Basisschmelze keine Metalloxide bilden und liegen in der fertigen Impflegierung in metallischer Form vor. Die metallische Form der Zusätze bleibt auch erhalten, wenn die Impflegierung in die Schmelze gegeben wird, weil der Kohlenstoff- überschuß die Sauerstoffaktivität der Schmelze zumindest reduziert oder ganz unterdrückt.In this connection, a method for producing the inoculation alloy is proposed according to the invention, in which the base alloy is first melted and the additives are added shortly before or during the cooling phase, which is characterized in that the base alloy C is added in an amount which suppresses the oxygen activity of the base alloy. When carbon is already added to the base alloy, then arises in the melt phase of the base alloy is an equilibrium reaction Si-C-0, the hauptsäch- lic h d ung / CO leads to Bil which escapes as a gas phase. The additives added later, in particular those which have a high oxygen activity, cannot then form any metal oxides in the cooling base melt and are present in metallic form in the finished inoculation alloy. The metallic form of the additives is also retained when the seed alloy is added to the melt because the excess carbon at least reduces or completely suppresses the oxygen activity of the melt.

Die Impflegierung kann bis zu 5 Gewichtsprozent, vorzugsweise 3 Gewichtsprozent, Kohlenstoff enthalten. Bei einer Impflegierung für perlitische GuBqualität wird die folgende Richtanalyse vorgeschlagen.

Figure imgb0001
The inoculating alloy can contain up to 5 percent by weight, preferably 3 percent by weight, of carbon. The following directional analysis is proposed for an inoculant for pearlitic GuB quality.
Figure imgb0001

Bei einer Impflegierung für ferritische GuBqualität wird die folgende Richtanalyse vorgeschlagen:

Figure imgb0002
The following directional analysis is proposed for a vaccine alloy for ferritic GuB quality:
Figure imgb0002

Im folgenden wird ein AusfUhrungsbeispiel der Erfindung beschrieben:An exemplary embodiment of the invention is described below:

Zur Herstellung einer Impflegierung der Richtanalyse Ca = 2,5 Gewichtsprozent, Al= 0,5 Gewichtsprozent, CeM = 1,0 Gewichtsprozent, Bi = 2,0 Gewichtsprozent, C = 3,0 Gewichtsprozent, Si = 75 Gewichtsprozent, Rest Fe wird zunächst eine Basislegierung aus Si und Fe bei einer Temperatur von 1400 Grad Celsius erschmolzen. Der Basislegierung wird C in einer Menge beigegeben, die einerseits die Sauerstoffaktivität der Basislegierung senkt und andererseits zu einem C-Gehalt von ca. 3,0 Gewichtsprozent in der fertigen Impflegierung führt. Kurz vor der Abkühlungsphase werden die Zusätze Ca, Al, Ce, Bi der Basisschmelze zugegeben. Die Impflegierung wird in körnige Form gebracht.To prepare a seed alloy of the directional analysis Ca = 2.5 percent by weight, Al = 0.5 percent by weight, CeM = 1.0 percent by weight, Bi = 2.0 percent by weight, C = 3.0 percent by weight, Si = 75 percent by weight, the rest Fe is first a base alloy of Si and Fe melted at a temperature of 1400 degrees Celsius. C is added to the base alloy in an amount that on the one hand lowers the oxygen activity of the base alloy and on the other hand leads to a C content of approx. 3.0 percent by weight in the finished inoculation alloy. Shortly before the cooling phase, the additives Ca, Al, Ce, Bi are added to the base melt. The inoculation alloy is brought into granular form.

Diese Impflegierung wird zur Herstellung eines duktilen GuBei - senssphärolithischer Gußqualität aus einer eutektischen Legierung in einer Menge von 0,3 Gewichtsprozent der in einem Gießpfännchen befindlichen Mg-vorbehandelten Schmelze kurz vor dem Abguß zugegeben. Bei der Abkühlung zeigt die Schmelze ein selbstspeisendes Verhalten. Die folgenden Tabellen geben die Ergebnisse von Vergleichsversuchen wieder; Tabelle I Versuchsergebnisse mit einer Impflegierung für ferritisches duktiles Gußeisen und Tabelle II mit einer Impflegierung für perlitisches Gußeisen:

Figure imgb0003
Figure imgb0004
This inoculant is used to produce a ductile GuBei - Spherolithic casting quality from a eutectic alloy in an amount of 0.3 percent by weight of the Mg-pretreated melt contained in a pouring pan was added shortly before the casting. The melt shows a self-feeding behavior when it cools down. The following tables show the results of comparative tests; Table I test results with an inoculating alloy for ferritic ductile cast iron and Table II with an inoculating alloy for pearlitic cast iron:
Figure imgb0003
Figure imgb0004

Unter a) sind jeweils Versuchsergebnisse zusammengefaßt, bei denen der prozentuale Gehalt verschiedener Zusätze variiert wurde. Unter b) sind die Versuchsergebnisse mit den jeweils optimalen Impflegierungen angegeben. Unter c) sind die Versuchsergebnisse mit der Impflegierung D aus der DE-OS 32 29 153 wiedergegeben. Die demgegenüber besseren Ergebnisse werden u.a. auf den relativ höheren Ca-Gehalt zurückgeführt.Test results are summarized under a), in which the percentage content of various additives was varied. Under b) the test results with the respective opti paint vaccine alloys specified. The test results with the vaccine alloy D from DE-OS 32 29 153 are reproduced under c). The better results are attributed, among other things, to the relatively higher Ca content.

Claims (6)

1. Impflegierung zur Herstellung von sphärolithischem Gußeisen, - aus einer Fe-Si-Basislegierung mit Zusätzen von mindestens einem Metall der Gruppe seltener Erden, von mindestens einem Element aus der Gruppe Erdalkali,von Bi und Al,dadurch gekennzeichnet , daß die Impflegierung über das Lösungsgleichgewicht der Fe-Si-Basislegierung hinaus C enthält und entsprechend metalloxidfrei ist.1. Inoculating alloy for the production of spherulitic cast iron, - from an Fe-Si base alloy with additions of at least one metal from the rare earth group, from at least one element from the group of alkaline earth metals, from Bi and Al, characterized in that the inoculating alloy has the Solution equilibrium of the Fe-Si base alloy also contains C and is accordingly free of metal oxides. 2. Impflegierung nach Anspruch 1, dadurch gekennzeichnet , daß sie bis zu 5 Gewichtsprozent C enthält.2. Inoculation alloy according to claim 1, characterized in that it contains up to 5 weight percent C. 3. Impflegierung nach Anspruch 1 oder 2, dadurch gekennzeichnet , daß sie 3 Gewichtsprozent C enthält.3. seed alloy according to claim 1 or 2, characterized in that it contains 3 weight percent C. 4. Impflegierung nach einem der Ansprüche 1 - 3 für perlitische Gußqualität, gekennzeichnet durch die Richtanalyse
Figure imgb0005
Figure imgb0006
4. Inoculating alloy according to one of claims 1-3 for pearlitic casting quality, characterized by the directional analysis
Figure imgb0005
Figure imgb0006
5. Impflegierung nach einem der Ansprüche 1 - 3 für ferritische Gußqualität, gekennzeichnet durch die Richtanalyse
Figure imgb0007
5. Inoculation alloy according to one of claims 1-3 for ferritic casting quality, characterized by the directional analysis
Figure imgb0007
6. Verfahren zum Herstellen einer Impflegierung nach einem der An. sprüche 1 - 5, wobei zunächst die Basislegierung erschmolzen und kurz vor oder während der Abkühlungsphase die Zusätze beigegeben werden, dadurch gekennzeichnet , daß der Basislegierung C in einer die Sauerstoffaktivität der Basislegierung unterdrückenden Menge zugegeben wird.6. A method for producing a vaccine alloy according to one of the An. Proverbs 1-5, wherein the base alloy is first melted and the additives are added shortly before or during the cooling phase, characterized in that the base alloy C is added in an amount which suppresses the oxygen activity of the base alloy.
EP85101529A 1984-03-15 1985-02-13 Inoculating alloy for the production of nodular cast iron Withdrawn EP0162194A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843409550 DE3409550C1 (en) 1984-03-15 1984-03-15 Inoculating alloy for the production of spherulitic cast iron
DE3409550 1984-03-15

Publications (1)

Publication Number Publication Date
EP0162194A1 true EP0162194A1 (en) 1985-11-27

Family

ID=6230612

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85101529A Withdrawn EP0162194A1 (en) 1984-03-15 1985-02-13 Inoculating alloy for the production of nodular cast iron

Country Status (2)

Country Link
EP (1) EP0162194A1 (en)
DE (1) DE3409550C1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317366A1 (en) * 1987-11-20 1989-05-24 Honda Giken Kogyo Kabushiki Kaisha Process for producing nodular cast iron
US4882769A (en) * 1988-07-05 1989-11-21 Gallimore Bruce A AM/FM radio with sunglass housing
RU2146295C1 (en) * 1999-06-09 2000-03-10 ООО "Ассоциация металлургов и инвесторов" Method of spheroidizing treatment of spherulitic iron
RU2170267C1 (en) * 2000-04-26 2001-07-10 Ганаго Олег Александрович Method of cast-iron inoculation by magnesium
FR2855186A1 (en) * 2003-05-20 2004-11-26 Pechiney Electrometallurgie Inoculating mixture containing bismuth and rare earth metals for treatment of molten iron during fabrication of thin iron components
CN109972026A (en) * 2019-04-15 2019-07-05 南京浦江合金材料股份有限公司 A kind of preparation process pouring method preparation silicon strontium inoculant using dam-type

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635534B1 (en) * 1988-08-12 1992-04-03 Pechiney Electrometallurgie PROCESS FOR OBTAINING SPHEROIDAL GRAPHITE FOUNDS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136508A1 (en) * 1970-07-23 1972-02-10 Pechiney New iron-silicon alloy, its production and use as a seed metal for gray and spheroidal graphite cast iron
US4189316A (en) * 1978-01-30 1980-02-19 Tulsky Proektno-Konstruktorsky Tekhnologichesky Institut Mashinostroenia Iron modifier and method of using same
DE3229153A1 (en) * 1981-08-04 1983-04-28 Nobel-Bozel, 92800 Puteaux, Hauts-de-Seine REMOTE ALLOYING FOR THE PREVIOUS VACCINE TREATMENT OF POWDERED AND UNCOVERED BALL GRAPHITE CASTING AND METHOD FOR TREATING THE LIQUID PIPE IRON WITH THIS REMOTE ALLOY
EP0090654A2 (en) * 1982-03-29 1983-10-05 Elkem Metals Company Alloy and process for producing ductile and compacted graphite cast irons

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136508A1 (en) * 1970-07-23 1972-02-10 Pechiney New iron-silicon alloy, its production and use as a seed metal for gray and spheroidal graphite cast iron
US4189316A (en) * 1978-01-30 1980-02-19 Tulsky Proektno-Konstruktorsky Tekhnologichesky Institut Mashinostroenia Iron modifier and method of using same
DE3229153A1 (en) * 1981-08-04 1983-04-28 Nobel-Bozel, 92800 Puteaux, Hauts-de-Seine REMOTE ALLOYING FOR THE PREVIOUS VACCINE TREATMENT OF POWDERED AND UNCOVERED BALL GRAPHITE CASTING AND METHOD FOR TREATING THE LIQUID PIPE IRON WITH THIS REMOTE ALLOY
EP0090654A2 (en) * 1982-03-29 1983-10-05 Elkem Metals Company Alloy and process for producing ductile and compacted graphite cast irons

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
METALS ABSTRACTS, Band 16, Mai 1983, Seite 134, Nr. 51-0496, Foxton, Cambridge, GB; F. LIETAERT u.a.: "Development of more powerful inoculants for spheroidal graphite irons" & FONDERIE BELGE, Juni 1982, 52(2), 5-18 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317366A1 (en) * 1987-11-20 1989-05-24 Honda Giken Kogyo Kabushiki Kaisha Process for producing nodular cast iron
US4882769A (en) * 1988-07-05 1989-11-21 Gallimore Bruce A AM/FM radio with sunglass housing
RU2146295C1 (en) * 1999-06-09 2000-03-10 ООО "Ассоциация металлургов и инвесторов" Method of spheroidizing treatment of spherulitic iron
RU2170267C1 (en) * 2000-04-26 2001-07-10 Ганаго Олег Александрович Method of cast-iron inoculation by magnesium
FR2855186A1 (en) * 2003-05-20 2004-11-26 Pechiney Electrometallurgie Inoculating mixture containing bismuth and rare earth metals for treatment of molten iron during fabrication of thin iron components
WO2004104252A1 (en) * 2003-05-20 2004-12-02 Pechiney Electrometallurgie Inoculant products comprising bismuth and rare earths
US7569092B2 (en) 2003-05-20 2009-08-04 Pechiney Electrometallurgie Inoculant products comprising bismuth and rare earths
CN109972026A (en) * 2019-04-15 2019-07-05 南京浦江合金材料股份有限公司 A kind of preparation process pouring method preparation silicon strontium inoculant using dam-type

Also Published As

Publication number Publication date
DE3409550C1 (en) 1985-06-20

Similar Documents

Publication Publication Date Title
DE69606060T2 (en) METHOD FOR REDUCING THE FORMATION OF PLATE-SHAPED BETAPHASES IN IRON-CONTAINING ALSI ALLOYS, IN PARTICULAR AL-Si-Mn-Fe ALLOYS
DE112014002442B4 (en) Cast iron of high strength and high damping capacity
DE2518367C3 (en) Method and casting mold for producing cast iron with spherical graphite
DE68906489T2 (en) METHOD FOR PRODUCING BALL GRAPHITE CAST IRON.
DE69702045T2 (en) VACCINE for low-sulfur gray cast iron
DE2136508C3 (en) Iron-silicon alloy for the inoculation of gray cast iron or cast iron with spheroidal graphite and process for their production
DE2937321C2 (en) Process for melting cast iron with compacted graphite by means of double modification
DE60031503T2 (en) Production of spheroidal graphite cast iron using an additional inoculation in the casting vessel
DE2823913C3 (en) Modifying agent for pig iron and process for its application
EP0162194A1 (en) Inoculating alloy for the production of nodular cast iron
DE69311542T2 (en) DETERMINATION OF CARBON EQUIVALENT IN STRUCTURALLY MODIFIED CAST IRON
DE1458423C3 (en) Additive for the production of nodular cast iron
DE2244092A1 (en) NICKEL-MAGNESIUM ALLOY
DE2000557C3 (en) Process for the production of spheroidal graphite cast iron
DE69806553T2 (en) Carbon steel or low alloy steel with improved machinability and process for producing this steel
DE2001495A1 (en) Process for the production of spheroidal graphite cast iron
EP0074979A1 (en) Method for the preparation of vermicular graphite cast iron and device allowing to implement such method
DE69909071T2 (en) METHOD FOR PRODUCING IRON WITH SPHERICAL GRAPHITE
DE1758820B2 (en) USING AN ALZNCNMG ALLOY
DE3809315A1 (en) Treatment alloy based on ferrosilicon or silicon, process for the preparation thereof and use thereof
DE2250165C3 (en) Nodularizing composition for use in the manufacture of spheroidal graphite cast iron
DE976573C (en) Process for producing cast iron with spherulitic graphite
DE102005062994B4 (en) Process for producing thick-walled castings
AT157096B (en) Process for cleaning and refining molten metals and alloys.
DE2847787C3 (en) Long-term inoculants and methods of inoculating cast iron melts

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): CH FR GB IT LI NL

17P Request for examination filed

Effective date: 19860107

17Q First examination report despatched

Effective date: 19861114

D17Q First examination report despatched (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19890530

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ABLEIDINGER, KARL, DR.-ING.

Inventor name: RABUS, DIETER, DR.-ING.

Inventor name: HEYER, HANS, DR.-ING.